![Ruth Adams](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Ruth Adams worked as Head-Clinical Operation at Vigeo Therapeutics, Inc. Ms. Adams worked as Vice President-Clinical Operations at Nuvalent, Inc. from 2020 to 2026.
Ms. Adams completed undergraduate education at The University of Southampton.
Anciens postes connus de Ruth Adams
| Sociétés | Poste | Fin |
|---|---|---|
| NUVALENT, INC. | Directeur Technique/Scientifique/R&D | 15/07/2026 |
Vigeo Therapeutics, Inc.
 Vigeo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures cancer drugs | Directeur Technique/Scientifique/R&D | - |
Formation de Ruth Adams
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
30
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
The University of Southampton
 The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vigeo Therapeutics, Inc.
Vigeo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures cancer drugs | Health Technology |
Nuvalent, Inc.
 Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
